524 related articles for article (PubMed ID: 22264787)
1. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.
Quante M; Bhagat G; Abrams JA; Marache F; Good P; Lee MD; Lee Y; Friedman R; Asfaha S; Dubeykovskaya Z; Mahmood U; Figueiredo JL; Kitajewski J; Shawber C; Lightdale CJ; Rustgi AK; Wang TC
Cancer Cell; 2012 Jan; 21(1):36-51. PubMed ID: 22264787
[TBL] [Abstract][Full Text] [Related]
2. Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.
Kong J; Sai H; Crissey MA; Jhala N; Falk GW; Ginsberg GG; Abrams JA; Nakagawa H; Wang K; Rustgi AK; Wang TC; Lynch JP
Oncotarget; 2015 Oct; 6(32):32980-3005. PubMed ID: 26460825
[TBL] [Abstract][Full Text] [Related]
3. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
[TBL] [Abstract][Full Text] [Related]
4. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
[TBL] [Abstract][Full Text] [Related]
6. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
7. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
8. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.
Ruol A; Parenti A; Zaninotto G; Merigliano S; Costantini M; Cagol M; Alfieri R; Bonavina L; Peracchia A; Ancona E
Cancer; 2000 Jun; 88(11):2520-8. PubMed ID: 10861428
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CDX2 expression in esophageal adenocarcinoma.
Vaninetti N; Williams L; Geldenhuys L; Porter GA; Guernsey DL; Casson AG
Mol Carcinog; 2009 Oct; 48(10):965-74. PubMed ID: 19415720
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
11. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
12. TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD).
Peitz U; Kouznetsova I; Wex T; Gebert I; Vieth M; Roessner A; Hoffmann W; Malfertheiner P
Peptides; 2004 May; 25(5):771-7. PubMed ID: 15177871
[TBL] [Abstract][Full Text] [Related]
13. Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.
Goldman A; Chen HD; Roesly HB; Hill KA; Tome ME; Dvorak B; Bernstein H; Dvorak K
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G292-302. PubMed ID: 21127259
[TBL] [Abstract][Full Text] [Related]
14. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
Souza RF
J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce Delta-like 1 expression via Cdx2-dependent pathway in the development of Barrett's esophagus.
Tamagawa Y; Ishimura N; Uno G; Aimi M; Oshima N; Yuki T; Sato S; Ishihara S; Kinoshita Y
Lab Invest; 2016 Mar; 96(3):325-37. PubMed ID: 26568294
[TBL] [Abstract][Full Text] [Related]
16. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
Lee Y; Urbanska AM; Hayakawa Y; Wang H; Au AS; Luna AM; Chang W; Jin G; Bhagat G; Abrams JA; Friedman RA; Varro A; Wang KK; Boyce M; Rustgi AK; Sepulveda AR; Quante M; Wang TC
Oncotarget; 2017 Jan; 8(1):203-214. PubMed ID: 27448962
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of Barrett esophagus: current evidence.
Krishnadath KK; Wang KK
Gastroenterol Clin North Am; 2015 Jun; 44(2):233-47. PubMed ID: 26021192
[TBL] [Abstract][Full Text] [Related]
18. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
Souza RF; Krishnan K; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells.
Morrow DJ; Avissar NE; Toia L; Redmond EM; Watson TJ; Jones C; Raymond DP; Litle V; Peters JH
Surgery; 2009 Oct; 146(4):714-21; discussion 721-2. PubMed ID: 19789031
[TBL] [Abstract][Full Text] [Related]
20. Esophageal adenocarcinoma arising in Barrett esophagus.
Zhang HY; Spechler SJ; Souza RF
Cancer Lett; 2009 Mar; 275(2):170-7. PubMed ID: 18703277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
